ADOCIA Reports Fourth Quarter 2024 Financial Results and Provides a Business Update
Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the research and development of innovative...
ADOCIA
